These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of Rab GTPases to study lipid trafficking in normal and sphingolipid storage disease fibroblasts. Choudhury A; Marks DL; Pagano RE Methods Enzymol; 2005; 403():166-82. PubMed ID: 16473585 [TBL] [Abstract][Full Text] [Related]
6. Membrane traffic in sphingolipid storage diseases. Pagano RE; Puri V; Dominguez M; Marks DL Traffic; 2000 Nov; 1(11):807-15. PubMed ID: 11208071 [TBL] [Abstract][Full Text] [Related]
7. Storage diseases: new insights into sphingolipid functions. Sillence DJ; Platt FM Trends Cell Biol; 2003 Apr; 13(4):195-203. PubMed ID: 12667757 [TBL] [Abstract][Full Text] [Related]
8. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Pagano RE Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):885-91. PubMed ID: 12803922 [TBL] [Abstract][Full Text] [Related]
9. Using fluorescent sphingolipid analogs to study intracellular lipid trafficking. Singh RD; Marks DL; Pagano RE Curr Protoc Cell Biol; 2007 Jun; Chapter 24():Unit 24.1. PubMed ID: 18228509 [TBL] [Abstract][Full Text] [Related]
10. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Cheng ZJ; Singh RD; Marks DL; Pagano RE Mol Membr Biol; 2006; 23(1):101-10. PubMed ID: 16611585 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol controls lipid endocytosis through Rab11. Takahashi M; Murate M; Fukuda M; Sato SB; Ohta A; Kobayashi T Mol Biol Cell; 2007 Jul; 18(7):2667-77. PubMed ID: 17475773 [TBL] [Abstract][Full Text] [Related]
12. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis. Trubiani O; Guarnieri S; Orciani M; Salvolini E; Di Primio R Int J Immunopathol Pharmacol; 2004; 17(3):293-300. PubMed ID: 15461863 [TBL] [Abstract][Full Text] [Related]
13. My journey into the world of sphingolipids and sphingolipidoses. Sandhoff K Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750 [TBL] [Abstract][Full Text] [Related]
14. Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Pagano RE; Chen CS Ann N Y Acad Sci; 1998 Jun; 845():152-60. PubMed ID: 9668349 [TBL] [Abstract][Full Text] [Related]
15. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. Sandhoff K; Kolter T; Van Echten-Deckert G Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348 [TBL] [Abstract][Full Text] [Related]
16. Metabolic and cellular bases of sphingolipidoses. Sandhoff K Biochem Soc Trans; 2013 Dec; 41(6):1562-8. PubMed ID: 24256255 [TBL] [Abstract][Full Text] [Related]
17. Glycosphingolipids in endocytic membrane transport. Sillence DJ; Platt FM Semin Cell Dev Biol; 2004 Aug; 15(4):409-16. PubMed ID: 15207831 [TBL] [Abstract][Full Text] [Related]
18. Sphingolipids and neuronal degeneration in lysosomal storage disorders. Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861 [TBL] [Abstract][Full Text] [Related]
19. Alternate raft pathways cooperate to mediate slow diffusion and efficient uptake of a sphingolipid tracer to degradative and recycling compartments. Zhang D; Manna M; Wohland T; Kraut R J Cell Sci; 2009 Oct; 122(Pt 20):3715-28. PubMed ID: 19773361 [TBL] [Abstract][Full Text] [Related]
20. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. Stein MP; Dong J; Wandinger-Ness A Adv Drug Deliv Rev; 2003 Nov; 55(11):1421-37. PubMed ID: 14597139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]